Bruker Analyst Price Targets - Benzinga

Bruker Corp

BRKRNASDAQ

Trade with Public

Trade with Public

$54.80

-1.74-3.08%

Dern. MÀJ: Oct 16, 4:00 PM

$54.80

-1.74-3.08%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Bruker Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bruker (BRKR).

Price Target Range — 13 Quarters

Analyst Consensus — 13 Analysts

7Buy

5Hold

1Sell

Consensus RatingBuy# Analysts13Avg. Consensus PT$63Upside to Avg. PT+14.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	JP Morgan	Casey Woodring	Downgrade	Overweight→Neutral	$60
Oct 13, 2026	TD Cowen	Kyle Boucher	PT Raise	Hold	$60→$62
Oct 7, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$58→$70
Oct 1, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$70→$72
Sep 29, 2026	Leerink Partners	Puneet Souda	PT Raise	Outperform	$60→$80
Sep 9, 2026	UBS	Dan Leonard	PT Raise	Neutral	$45→$65
Aug 5, 2026	Citigroup	Brendan Digan	PT Cut	Neutral	$60→$53
Jul 8, 2026	Citigroup	Patrick Donnelly	PT Raise	Neutral	$44→$60
Jul 7, 2026	Leerink Partners	Puneet Souda	PT Raise	Outperform	$60→$70
Jun 29, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$50→$70
Jun 24, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$53→$60
Jun 8, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$55→$65
Jun 2, 2026	Wolfe Research	Mike Polark	Assumes	Peer Perform	—
May 7, 2026	UBS	Dan Leonard	PT Raise	Neutral	$40→$45
May 7, 2026	Citigroup	Patrick Donnelly	PT Raise	Neutral	$40→$44
May 7, 2026	TD Cowen	Kyle Boucher	PT Raise	Hold	$43→$45
May 7, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$45→$53
Apr 15, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$50→$45
Apr 14, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$50→$45
Mar 30, 2026	Guggenheim	Subbu Nambi	PT Cut	Buy	$58→$50

More with Benzinga EdgeGet Access

Analyst Ratings News

This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Analysts downgraded CTNM, CC, ACI, BRKR and SAFE; targets fell for CTNM, CC and ACI, while BRKR received a new $60 target.

Avi Kapoor

PRO
JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target

JP Morgan analyst Casey Woodring downgrades Bruker (NASDAQ:BRKR) from Overweight to Neutral and announces $60 price target.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Bruker, Raises Price Target to $62

TD Cowen analyst Kyle Boucher maintains Bruker (NASDAQ:BRKR) with a Hold and raises the price target from $60 to $62.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Bruker, Raises Price Target to $70

Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Bruker, Raises Price Target to $72

Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $70 to $72.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $80

Leerink Partners analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $60 to $80.

Benzinga Newsdesk